Studies have shown that NEDD4 is dysregulated in various types of cancer, potentially promoting tumor development by affecting cell proliferation, apoptosis, metabolism, migration, and invasion (Mao et al. 2022; Shao et al. 2018). The gene discussed is NEDD4; the disease is neoplasm.